ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
May 08, 2021Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million. -
Cellares Expands Cell Therapy Manufacturing Capabilities
May 06, 2021Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, has secured $82 million in a Series B round, bringing total funding to date to $100 million.
Pharma Sources Insight January 2025
